These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 30876420)

  • 1. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry.
    Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Kahn N; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Oqueka T; Frankenberger M; Behr J
    Respir Res; 2019 Mar; 20(1):59. PubMed ID: 30876420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry.
    Kreuter M; Swigris J; Pittrow D; Geier S; Klotsche J; Prasse A; Wirtz H; Koschel D; Andreas S; Claussen M; Grohé C; Wilkens H; Hagmeyer L; Skowasch D; Meyer JF; Kirschner J; Gläser S; Herth FJF; Welte T; Neurohr C; Schwaiblmair M; Held M; Bahmer T; Frankenberger M; Behr J
    Respir Res; 2017 Jul; 18(1):139. PubMed ID: 28709421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.
    Kreuter M; Wuyts WA; Wijsenbeek M; Bajwah S; Maher TM; Stowasser S; Male N; Stansen W; Schoof N; Orsatti L; Swigris J
    Respir Res; 2020 Jan; 21(1):36. PubMed ID: 32000772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis: A Cross-Sectional Analysis of the IPF-PRO Registry.
    O'Brien EC; Hellkamp AS; Neely ML; Swaminathan A; Bender S; Snyder LD; Culver DA; Conoscenti CS; Todd JL; Palmer SM; Leonard TB;
    Chest; 2020 May; 157(5):1188-1198. PubMed ID: 31954102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The St. George's Respiratory Questionnaire as a prognostic factor in IPF.
    Furukawa T; Taniguchi H; Ando M; Kondoh Y; Kataoka K; Nishiyama O; Johkoh T; Fukuoka J; Sakamoto K; Hasegawa Y
    Respir Res; 2017 Jan; 18(1):18. PubMed ID: 28095852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life and Healthcare Resource Use in a Real-world Patient Population with Idiopathic Pulmonary Fibrosis: The PROOF Registry.
    Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Rizzo S; Kirchgaessler KU; Bartley K; Bondue B
    Pulm Ther; 2022 Jun; 8(2):181-194. PubMed ID: 35429319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis.
    Doubková M; Švancara J; Svoboda M; Šterclová M; Bartoš V; Plačková M; Lacina L; Žurková M; Binková I; Bittenglová R; Lošťáková V; Merta Z; Šišková L; Tyl R; Lisá P; Šuldová H; Petřík F; Pšikalová J; Řihák V; Snížek T; Reiterer P; Homolka J; Musilová P; Lněnička J; Palúch P; Hrdina R; Králová R; Hortvíková H; Strenková J; Vašáková M
    Clin Respir J; 2018 Apr; 12(4):1526-1535. PubMed ID: 28862397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the IPF-specific version of St. George's Respiratory Questionnaire.
    Prior TS; Hoyer N; Shaker SB; Davidsen JR; Yorke J; Hilberg O; Bendstrup E
    Respir Res; 2019 Aug; 20(1):199. PubMed ID: 31462235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.
    Glaspole IN; Chapman SA; Cooper WA; Ellis SJ; Goh NS; Hopkins PM; Macansh S; Mahar A; Moodley YP; Paul E; Reynolds PN; Walters EH; Zappala CJ; Corte TJ
    Respirology; 2017 Jul; 22(5):950-956. PubMed ID: 28166611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry.
    Wuyts WA; Dahlqvist C; Slabbynck H; Schlesser M; Gusbin N; Compere C; Maddens S; Lee YC; Kirchgaessler KU; Bartley K; Bondue B
    Respir Res; 2019 Oct; 20(1):231. PubMed ID: 31651324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness and minimal clinically important difference of SGRQ-I and K-BILD in idiopathic pulmonary fibrosis.
    Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Bendstrup E
    Respir Res; 2020 Apr; 21(1):91. PubMed ID: 32316976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a derived version of the IPF-specific Saint George's Respiratory Questionnaire.
    Prior TS; Hoyer N; Shaker SB; Davidsen JR; Hilberg O; Patel H; Bendstrup E
    Respir Res; 2021 Oct; 22(1):259. PubMed ID: 34610840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry.
    Case AH; Hellkamp AS; Neely ML; Bender S; Dilling DF; Gulati M; Hotchkin DL; Huie TJ; Lancaster L; Snyder LD; Conoscenti CS; Palmer SM
    Ann Am Thorac Soc; 2020 Jun; 17(6):699-705. PubMed ID: 32040340
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry.
    Snyder L; Neely ML; Hellkamp AS; O'Brien E; de Andrade J; Conoscenti CS; Leonard T; Bender S; Gulati M; Culver DA; Kaner RJ; Palmer S; Kim HJ;
    Respir Res; 2019 May; 20(1):105. PubMed ID: 31142314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting.
    Jordon LH; Ganeshan B; Nadeem I; Hoy L; Mahdi N; Porter JC; Groves A; Win T
    BMJ Open; 2024 May; 14(5):e081103. PubMed ID: 38816048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.
    Swigris JJ; Han M; Vij R; Noth I; Eisenstein EL; Anstrom KJ; Brown KK; Fairclough D
    Respir Med; 2012 Oct; 106(10):1447-55. PubMed ID: 22801586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life does not predict mortality in idiopathic pulmonary fibrosis.
    Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishimura K; Ogawa T; Watanabe F; Arizono S; Tohda Y
    Sarcoidosis Vasc Diffuse Lung Dis; 2012 Oct; 29(2):113-8. PubMed ID: 23461073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden.
    Kalafatis D; Gao J; Pesonen I; Carlson L; Sköld CM; Ferrara G
    BMC Pulm Med; 2019 Nov; 19(1):222. PubMed ID: 31771560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation to Spanish and Validation of the Specific Saint George's Questionnaire for Idiopathic Pulmonary Fibrosis.
    Capparelli I; Fernandez M; Saadia Otero M; Steimberg J; Brassesco M; Campobasso A; Palacios S; Caro F; Alberti ML; Rabinovich RA; Paulin F
    Arch Bronconeumol (Engl Ed); 2018 Feb; 54(2):68-73. PubMed ID: 29102341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SF-36 and SGRQ: validity and first look at minimum important differences in IPF.
    Swigris JJ; Brown KK; Behr J; du Bois RM; King TE; Raghu G; Wamboldt FS
    Respir Med; 2010 Feb; 104(2):296-304. PubMed ID: 19815403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.